Development of an RIA-based primary screen for IL-1 antagonists
Identifieur interne : 003205 ( Main/Merge ); précédent : 003204; suivant : 003206Development of an RIA-based primary screen for IL-1 antagonists
Auteurs : Bruce L. Maloff [États-Unis] ; Joan E. Shaw [États-Unis] ; Theresa M. Di Meo [États-Unis] ; Diane Fox [États-Unis] ; Elaine M. Bruin [États-Unis]Source :
- Clinica Chimica Acta [ 0009-8981 ] ; 1989.
English descriptors
- Teeft :
- Arachidonic acid, Assay, Bioresponse, Cell concentration, Cetus, Cetus device, Cetus system, Clin, Control conditions, Dinarello, Fetal, Fetal calf serum, Fibroblast, Final concentration, Incubation period, Indomethacin, Inflammation, Maloff, Primary screen, Prostaglandin, Radioimmunoassay, Rheumatoid, Rheumatoid arthritis, Sarstedt, Scintillation, Signal transduction, Subsequent radioimmunoassay, Test compounds.
Url:
DOI: 10.1016/0009-8981(89)90298-2
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002415
- to stream Istex, to step Curation: 002415
- to stream Istex, to step Checkpoint: 001F01
Links to Exploration step
ISTEX:858D39FB3EED5EBC3DD234C1B8E03FC8E84C7246Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Development of an RIA-based primary screen for IL-1 antagonists</title>
<author><name sortKey="Maloff, Bruce L" sort="Maloff, Bruce L" uniqKey="Maloff B" first="Bruce L." last="Maloff">Bruce L. Maloff</name>
</author>
<author><name sortKey="Shaw, Joan E" sort="Shaw, Joan E" uniqKey="Shaw J" first="Joan E." last="Shaw">Joan E. Shaw</name>
</author>
<author><name sortKey="Di Meo, Theresa M" sort="Di Meo, Theresa M" uniqKey="Di Meo T" first="Theresa M." last="Di Meo">Theresa M. Di Meo</name>
</author>
<author><name sortKey="Fox, Diane" sort="Fox, Diane" uniqKey="Fox D" first="Diane" last="Fox">Diane Fox</name>
</author>
<author><name sortKey="Bruin, Elaine M" sort="Bruin, Elaine M" uniqKey="Bruin E" first="Elaine M." last="Bruin">Elaine M. Bruin</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:858D39FB3EED5EBC3DD234C1B8E03FC8E84C7246</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1016/0009-8981(89)90298-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-J5145K4W-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002415</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002415</idno>
<idno type="wicri:Area/Istex/Curation">002415</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F01</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F01</idno>
<idno type="wicri:doubleKey">0009-8981:1989:Maloff B:development:of:an</idno>
<idno type="wicri:Area/Main/Merge">003205</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Development of an RIA-based primary screen for IL-1 antagonists</title>
<author><name sortKey="Maloff, Bruce L" sort="Maloff, Bruce L" uniqKey="Maloff B" first="Bruce L." last="Maloff">Bruce L. Maloff</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>E.I. Du Pont de Nemours & Co., Inc., Experimental Station, Medical Products Department, Immunopharmacology Section, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shaw, Joan E" sort="Shaw, Joan E" uniqKey="Shaw J" first="Joan E." last="Shaw">Joan E. Shaw</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>E.I. Du Pont de Nemours & Co., Inc., Experimental Station, Medical Products Department, Immunopharmacology Section, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Di Meo, Theresa M" sort="Di Meo, Theresa M" uniqKey="Di Meo T" first="Theresa M." last="Di Meo">Theresa M. Di Meo</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>E.I. Du Pont de Nemours & Co., Inc., Experimental Station, Medical Products Department, Immunopharmacology Section, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Fox, Diane" sort="Fox, Diane" uniqKey="Fox D" first="Diane" last="Fox">Diane Fox</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>E.I. Du Pont de Nemours & Co., Inc., Experimental Station, Medical Products Department, Immunopharmacology Section, Wilmington</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bruin, Elaine M" sort="Bruin, Elaine M" uniqKey="Bruin E" first="Elaine M." last="Bruin">Elaine M. Bruin</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Delaware</region>
</placeName>
<wicri:cityArea>E.I. Du Pont de Nemours & Co., Inc., Experimental Station, Medical Products Department, Immunopharmacology Section, Wilmington</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinica Chimica Acta</title>
<title level="j" type="abbrev">CCA</title>
<idno type="ISSN">0009-8981</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1989">1989</date>
<biblScope unit="volume">180</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="73">73</biblScope>
<biblScope unit="page" to="78">78</biblScope>
</imprint>
<idno type="ISSN">0009-8981</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0009-8981</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Arachidonic acid</term>
<term>Assay</term>
<term>Bioresponse</term>
<term>Cell concentration</term>
<term>Cetus</term>
<term>Cetus device</term>
<term>Cetus system</term>
<term>Clin</term>
<term>Control conditions</term>
<term>Dinarello</term>
<term>Fetal</term>
<term>Fetal calf serum</term>
<term>Fibroblast</term>
<term>Final concentration</term>
<term>Incubation period</term>
<term>Indomethacin</term>
<term>Inflammation</term>
<term>Maloff</term>
<term>Primary screen</term>
<term>Prostaglandin</term>
<term>Radioimmunoassay</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Sarstedt</term>
<term>Scintillation</term>
<term>Signal transduction</term>
<term>Subsequent radioimmunoassay</term>
<term>Test compounds</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:858D39FB3EED5EBC3DD234C1B8E03FC8E84C7246 |texte= Development of an RIA-based primary screen for IL-1 antagonists }}
This area was generated with Dilib version V0.6.33. |